ArticleESMO gastrointestinal oncology2024

Sidedness and addition of chemotherapy associated with treatment outcomes of regorafenib for metastatic colorectal cancer: a population-wide cohort study.

T-C Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.